Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neumega in Type 1 Von Willebrand Disease Surgery
NCT00524225Phase 2Terminated
- Start
- Feb 2008
- Primary completion
- Jun 2012
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of oprelvekin in Von Willebrand disease type 1. Started Feb 2008; status: terminated.
02
Drugs
oprelvekin
03
Conditions
Von Willebrand disease type 1
Beyond the preview
Go deeper on NCT00524225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00524225.